Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Registration - Consultant

Canadian Generic Pharmaceutical Association / L’Association canadienne du médicament générique / LESTER SCHEININGER, Consultant

Registration Information

Client name: Canadian Generic Pharmaceutical Association / L’Association canadienne du médicament générique
Lobbyist name: LESTER SCHEININGER, Consultant
Initial registration start date: 2004-11-11
Registration status: Inactive
Registration Number: 776848-3757

Associated Communications

Total Number of Communication Reports: 61

Monthly communication reports in the last 6 months: 0

Version 1 of 20 (2004-11-11 to 2005-06-10)

Version 1 of 20 (2004-11-11 to 2005-06-10) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Registrant

Consultant lobbyist name: LESTER SCHEININGER    Lobbyist business address
Consulting firm: BRESVER, GROSSMAN, SCHEININGER & CHAPMAN LLP
2900 - 390 BAY STREET
TORONTO, ON  M5H 2Y2
Canada
Position: PARTNER
Telephone number: 416-867-8036  
Fax number: 416-440-7885  
 
Former public office holder: N/A. Disclosure of this information was not a requirement prior to June 20, 2005.
Payment is contingent on the success of the undertaking: No

Information about Lobbyist

Consultant lobbyist name: LESTER SCHEININGER
Business address: 390 BAY STREET, SUITE 2900
TORONTO, ON  M5H 2Y2
Canada
Telephone number: 416-867-8036  
Fax number: 416-867-8036  

B. Information about Client

Client: Canadian Generic Pharmaceutical Association / L’Association canadienne du médicament générique
4120 YONGE STREET, SUITE 409
TORONTO, ON  M2P 2B8
Canada
Telephone number: 416-223-2333
Fax number: 416-223-2425  
 
Client Representative: JIM KEON
 
Parent: The client is not a subsidiary of any other parent companies.
Coalition: The client is not a coalition.
Subsidiary: The client does not have any subsidiaries that could be affected by the outcome of the undertaking.
Individual, organization or corporation: The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Health, Industry, Intellectual Property, International Trade, Science and Technology
 

Details Regarding the Identified Subject Matter

Categories Description
Bill or Resolution PATENT ACT; FOOD AND DRUG ACT
Regulation PATENTED MEDICINES NOTICE OF COMPLIANCE REGULATIONS



Responsible Officer Name

This is the responsible officer name as provided in the most recent registration for the corporation or organization.

Name Change History:

Canadian Generic Pharmaceutical Association/L’Association canadienne du médicament générique

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name From To
Canadian Generic Pharmaceutical Association/L’Association canadienne du médicament générique 2008-08-13 2021-06-15

The following names have been used before July 2, 2008

  • Canadian Generic Pharmaceutical Association/L’Association canadienne du médicament générique
  • Canadian Generic Pharmaceutical Association/L’Association canadienne du médicament générique

Responsible Officer Change History

Canadian Generic Pharmaceutical Association / L’Association canadienne du médicament générique

Responsible Officer History
Responsible Officer Name From (YYYY-MM-DD) To (YYYY-MM-DD)

All Monthly Communication Reports for Canadian Generic Pharmaceutical Association / L’Association canadienne du médicament générique

LESTER SCHEININGER (Consultant)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-61 of 61

  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Tyler Meredith, Director of Policy | Office of the Minister of Finance | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2020-03-06
    Posted date: 2020-04-15
    Communication number: 3757-466494 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Monique Lugli, Chief of Staff | Office of Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2019-05-09
    Posted date: 2019-05-13
    Communication number: 3757-451956 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Shaun Chen, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-05-09
    Posted date: 2019-05-13
    Communication number: 3757-451955 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Raj Saini, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-05-09
    Posted date: 2019-05-13
    Communication number: 3757-451954 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Kamal Khera, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-05-09
    Posted date: 2019-05-13
    Communication number: 3757-451953 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Adam Vaughan, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-05-09
    Posted date: 2019-05-13
    Communication number: 3757-451952 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Julie Dabrusin, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-04-15
    Posted date: 2019-04-29
    Communication number: 3757-450888 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Jean Yip, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-03-18
    Posted date: 2019-04-15
    Communication number: 3757-448569 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Wayne Easter, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-03-18
    Posted date: 2019-04-15
    Communication number: 3757-448568 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-03-18
    Posted date: 2019-04-15
    Communication number: 3757-448567 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Francesco Sorbara, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-03-18
    Posted date: 2019-04-15
    Communication number: 3757-448566 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Kim Rudd, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-03-18
    Posted date: 2019-04-15
    Communication number: 3757-448565 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • David McNaughton, Ambassador | Embassy of Canada to the United States | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2019-03-04
    Posted date: 2019-03-17
    Communication number: 3757-448276 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Peter Fragiskatos, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-02-25
    Posted date: 2019-05-13
    Communication number: 3757-451957 (amended from 3757-446346) View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • James Maloney, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-02-25
    Posted date: 2019-03-01
    Communication number: 3757-446352 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Robert-Falcon Ouellette, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-02-25
    Posted date: 2019-03-01
    Communication number: 3757-446349 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Judy Sgro, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-02-25
    Posted date: 2019-03-15
    Communication number: 3757-446343 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Deb Schulte, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-02-25
    Posted date: 2019-03-15
    Communication number: 3757-446339 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Jennifer O'Connell, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-02-25
    Posted date: 2019-03-15
    Communication number: 3757-446333 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Sven Spengemann, Member of Parliament | Parliament of Canada | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development
    Communication date: 2019-01-24
    Posted date: 2019-02-15
    Communication number: 3757-444286 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Peter Fonseca, Member of Parliament | Parliament of Canada | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development
    Communication date: 2019-01-24
    Posted date: 2019-02-15
    Communication number: 3757-444285 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • David McNaughton, Ambassador | Embassy of Canada to the United States | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2017-09-25
    Posted date: 2017-10-22
    Communication number: 3757-410531 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Caroline Pitfield, Director of Policy | Office of the Minister | Health Canada (HC)
    • Jordan Crosby, Special Assistant (Ontario) | Office of the Minister | Health Canada (HC)
    • Kathryn Nowers, Policy Advisor | Office of the Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2017-03-30
    Posted date: 2017-04-15
    Communication number: 3757-397701 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Lindsay Hunter, Ontario Regional Desk, Operations | Prime Minister's Office | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, International Trade, Science and Technology, Economic Development
    Communication date: 2017-01-16
    Posted date: 2017-02-14
    Communication number: 3757-394090 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Shaun Govender, Special Assistant-Regional Economical Development | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
    • Parvinder Sachdeva, Policy Advisor | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
    • Navdeep Bains, Minister of Innovation, Science and Economic Development | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2016-11-16
    Posted date: 2016-12-15
    Communication number: 3757-388873 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Kirstie Duncan, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2015-08-17
    Posted date: 2015-08-28
    Communication number: 3757-360569 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Judy Sgro, Member of Parliament | House of Commons
    • Scott Brison, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, International Trade
    Communication date: 2015-06-25
    Posted date: 2015-07-14
    Communication number: 3757-358003 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Sabina Saini, Senior Manager of Policy,Research and Planning | Office of the Leader of the Liberal Party of Canada | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2015-06-22
    Posted date: 2015-07-14
    Communication number: 3757-358004 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Murray Rankin, Member of Parliament | House of Commons
    • Chandra Pasma, Issues Coordinator | Office of the Leader of the Official Opposition | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2015-06-22
    Posted date: 2015-07-14
    Communication number: 3757-358002 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Bonnie Crombie, MP | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2011-04-05
    Posted date: 2011-05-17
    Communication number: 3757-172104 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Maria Minna, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-08
    Posted date: 2011-04-16
    Communication number: 3757-170070 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Dave McKay, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-08
    Posted date: 2011-04-16
    Communication number: 3757-170069 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Ruby Dhalla, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-08
    Posted date: 2011-04-16
    Communication number: 3757-170068 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Scott Brison, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170067 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Massimo Paceti, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170066 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • David Smith, Senator | Senate of Canada

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170065 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Frank Mahovlich, Senator | Senate of Canada

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170064 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Art Eggleton, Senator | Senate of Canada
    • Art Eggleton, Senator | Senate of Canada

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170063 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Luch Durante, Senior Special Assistant | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170062 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Bryon Wilfert, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170061 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Allan Tonks, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170060 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Michelle Simson, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170059 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Judy Sgro, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170058 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Anthony Rota, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170057 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Yasmin Ratansi, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170056 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Rob Oliphant, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170055 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Maria Minna, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170054 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • John McCallum, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170053 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Derek Lee, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170052 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Andrew Kania, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170051 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Mark Holland, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170050 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Ken Dryden, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170049 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Bonnie Crombie, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170048 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Carolyn Bennett, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170047 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Mauril Belanger, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170046 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Glenn Pearson, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170045 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Paul Szabo, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 3757-170044 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Mario Silva, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2011-02-11
    Posted date: 2011-03-16
    Communication number: 3757-168019 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Navdeep Bains, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2011-02-11
    Posted date: 2011-03-16
    Communication number: 3757-168018 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • David Smith, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2011-02-11
    Posted date: 2011-03-16
    Communication number: 3757-168016 View associated registration
  • Canadian Generic Pharmaceutical Association
    Consultant: LESTER SCHEININGER
    Designated Public Office Holders who participated in the communication:
    • Bob Rae, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2011-02-11
    Posted date: 2011-03-16
    Communication number: 3757-167388 View associated registration

Public offices held:


Date Modified: